MYC’xing it up: zebrafish B ALL models provide insight into MYC-driven disease and relapse
MYC’xing it up: zebrafish B ALL models provide insight into MYC-driven disease and relapse |
|
https://doi.org/10.18632/oncotarget.27644
Diana Sá da Bandeira,
and Wilson K. Clements
|
| 2372-2374 |
Bacteriome and mycobiome and bacteriome-mycobiome interactions in head and neck squamous cell carcinoma
Bacteriome and mycobiome and bacteriome-mycobiome interactions in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27629
Elizabeth Shay,
Naseer Sangwan,
Roshan Padmanabhan,
Scott Lundy,
Brian Burkey,
and Charis Eng
|
| 2375-2386 |
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit |
|
https://doi.org/10.18632/oncotarget.27630
Hee-Don Chae,
Ritika Dutta,
Bruce Tiu,
Fieke W. Hoff,
Benedetta Accordi,
Valentina Serafin,
Minyoung Youn,
Min Huang,
Nathan Sumarsono,
Kara L. Davis,
Norman J. Lacayo,
Martina Pigazzi,
Terzah M. Horton,
Steven M. Kornblau,
and Kathleen M. Sakamoto
|
| 2387-2403 |
Mutation profile of primary subungual melanomas in Caucasians
Mutation profile of primary subungual melanomas in Caucasians |
|
https://doi.org/10.18632/oncotarget.27642
Aneta Borkowska,
Anna Szumera-Ciećkiewicz,
Mateusz Spałek,
Paweł Teterycz,
Anna Czarnecka,
Artur Kowalik,
and Piotr Rutkowski
|
| 2404-2413 |
Postoperative atrial fibrillation does not impact on overall survival after esophagectomy in patients with thoracic esophageal cancer: results from a randomized, double-blind, placebo-controlled trial
Postoperative atrial fibrillation does not impact on overall survival after esophagectomy in patients with thoracic esophageal cancer: results from a randomized, double-blind, placebo-controlled trial |
|
https://doi.org/10.18632/oncotarget.27643
Toshiyasu Ojima,
Masaki Nakamura,
Keiji Hayata,
Junya Kitadani,
Masahiro Katsuda,
Mikihito Nakamori,
Akihiro Takeuchi,
Shimpei Maruoka,
Naoki Fukuda,
Shinta Tominaga,
Hideki Motobayashi,
and Hiroki Yamaue
|
| 2414-2423 |
Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter
Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter |
|
https://doi.org/10.18632/oncotarget.27645
Rive Sarfstein,
and Haim Werner
|
| 2424-2437 |
Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1
Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1 |
|
https://doi.org/10.18632/oncotarget.27646
Erik L. Brincks,
James Adams,
Lifu Wang,
Benjamin Turner,
Agnieszka Marcinowicz,
Jiyuan Ke,
Michael Essmann,
Lucía M. Mautino,
Clarissa Van Allen,
Sanjeev Kumar,
Nicholas Vahanian,
Charles Link,
and Mario R. Mautino
|
| 2438-2461 |
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy |
|
https://doi.org/10.18632/oncotarget.27403
Caroline M. Robb,
Smit Kour,
Jacob I. Contreras,
Ekta Agarwal,
Carter J. Barger,
Sandeep Rana,
Yogesh Sonawane,
Beth K. Neilsen,
Margaret Taylor,
Smitha Kizhake,
Rhishikesh N. Thakare,
Sanjib Chowdhury,
Jing Wang,
Jennifer D. Black,
Michael A. Hollingsworth,
Michael G. Brattain,
and Amarnath Natarajan
|
| 2462-2463 |
